1-3 of 3
Michelle E. Kho
Close
Sort by
Journal Articles

Potential Impact of Pathologic Review on Therapy in Non-Hodgkin’s Lymphoma (NHL): Analysis from the National Comprehensive Cancer Network (NCCN) NHL Outcomes Project.

Ann LaCasce, Joyce Niland, Michelle E. Kho, Anna terVeer, Jonathan W. Friedberg, Maria A. Rodriguez, Myron S. Czuczman, Michael Millenson, Andrew D. Zelenetz, Auayporn P. Nademanee, Jane C. Weeks
Journal: Blood
Blood (2005) 106 (11): 2816.
https://doi.org/10.1182/blood.V106.11.2816.2816
Published: 2005
Journal Articles

Age Significantly Influences Presentation and Patterns of Care in Patients with Newly Diagnosed Diffuse Large Cell Lymphoma (DLCL): Collective Data from 5 Centers Participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project.

Maria Alma Rodriguez, MD, Myron S. Czuczman, MD, Jonathan W. Friedberg, MD, Michelle E. Kho, MSc, Ann S. LaCasce, MD, Michael Millenson, MD, Nademanee Auayporn, MD, Joyce Niland, PhD, Anna Ter Veer, MS, Andrew D. Zelenetz, MD, Jane C. Weeks, MD
Journal: Blood
Blood (2005) 106 (11): 1335.
https://doi.org/10.1182/blood.V106.11.1335.1335
Published: 2005
Journal Articles

Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Follicular (FL), Mantle Cell (MCL), and Diffuse Large B Cell (DLCL) Non-Hodgkin’s Lymphoma (NHL) in 5 United States Comprehensive Cancer Centers: An Analysis from the National Comprehensive Cancer Network (NCCN) NHL Outcomes Project.

Jonathan W. Friedberg, MD, MMSc, Michelle E. Kho, PT, MSc, Eva M. Lepisto, MSc, MA, M. Alma Rodriguez, MD, Anna TerVeer, MSc, Ann S. LaCasce, MD, Auyporn P. Nademanee, MD, Michael Millenson, MD, Myron Czuczman, MD, Joyce Niland, PhD, Andrew D. Zelenetz, MD, PhD, Jane C. Weeks, MD, MSc
Journal: Blood
Blood (2004) 104 (11): 1391.
https://doi.org/10.1182/blood.V104.11.1391.1391
Published: 2004